Neurocrine Biosciences | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 1.46B 1.86B 2025-03
Acadia Pharmaceuticals USD 822.38M 57.14M 2025-06
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
ALKERMES USD 1.62B 113M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 7.43B 1.22B 2025-06
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Cytokinetics USD -737440000 471.03M 2025-06
Dynavax Technologies USD 494.16M 36.78M 2025-06
Exelixis USD 2.03B 97.49M 2025-07
Gilead Sciences USD 19.67B 596M 2025-06
Halozyme Therapeutics USD 332.75M 149.52M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Prothena USD 486.93M 47.44M 2024-12
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Repligen USD 1.99B 12.76M 2025-03
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Teva Pharmaceutical Industries USD 6.83B 572M 2025-06
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06


Neurocrine Biosciences Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.